The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.

Sukul, Devraj

The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium. [electronic resource] - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions Nov 2017 - 724-732 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study

1522-726X

10.1002/ccd.27001 doi


Aged
Anticoagulants--adverse effects
Antithrombins--adverse effects
Blue Cross Blue Shield Insurance Plans
Comparative Effectiveness Research
Coronary Artery Disease--complications
Female
Hemorrhage--chemically induced
Heparin--adverse effects
Hirudins--adverse effects
Humans
Logistic Models
Male
Michigan
Middle Aged
Odds Ratio
Peptide Fragments--adverse effects
Percutaneous Coronary Intervention--adverse effects
Propensity Score
Recombinant Proteins--adverse effects
Registries
Renal Dialysis--adverse effects
Renal Insufficiency, Chronic--complications
Retrospective Studies
Risk Factors
Stents
Thrombosis--diagnosis
Time Factors
Treatment Outcome